What is Cytokinetics ROE % Adjusted to Book Value?
Cytokinetics's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Cytokinetics's PB Ratio for the quarter that ended in Mar. 2024 was N/A.
Cytokinetics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.
Cytokinetics ROE % Adjusted to Book Value Historical Data
The historical data trend for Cytokinetics's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cytokinetics's ROE % Adjusted to Book Value
For the Biotechnology subindustry, Cytokinetics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cytokinetics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Cytokinetics's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Cytokinetics's ROE % Adjusted to Book Value falls into.
Cytokinetics ROE % Adjusted to Book Value Calculation
Cytokinetics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cytokinetics ROE % Adjusted to Book Value Related Terms
Thank you for viewing the detailed overview of Cytokinetics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CYTK has been successfully added to your 